Corza Medical Opens State-of-the-Art Ophthalmology Center of Technology and Innovation, Demonstrating Commitment to Global Eye Care Community
30 nov. 2023 08h05 HE
|
Corza Medical Inc.
Corza Medical opens a new Ophthalmology Center of Technology and Innovation in MO to develop next-gen devices for eye treatments and enhance R&D.
Corza Medical & Envision announce strategic partnership
28 sept. 2023 08h05 HE
|
Corza Medical Inc.
Corza Medical and Envision announce today that they have entered into a strategic partnership to propel ophthalmic health forward
Corza Medical unterzeichnet endgültige Vereinbarung zur Übernahme des TachoSil-Produktionsbetriebs von Takeda
26 avr. 2023 12h45 HE
|
Corza Medical Inc.
WESTWOOD, Massachusetts, April 26, 2023 (GLOBE NEWSWIRE) -- Corza Medical hat heute bekanntgegeben, dass das Unternehmen mit einer Tochtergesellschaft der Takeda Pharmaceuticals Company...
Corza Medical signe un accord définitif pour faire l'acquisition des sites de fabrication du TachoSil de Takeda
26 avr. 2023 12h45 HE
|
Corza Medical Inc.
WESTWOOD, Massachusetts, 26 avr. 2023 (GLOBE NEWSWIRE) -- Corza Medical a annoncé avoir signé un accord définitif avec une filiale de Takeda Pharmaceuticals Company (TSE:4502/NYSE:TAK) (« Takeda »)...
Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations
26 avr. 2023 09h03 HE
|
Corza Medical Inc.
WESTWOOD, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Corza Medical announced today that it has entered into a definitive agreement with a subsidiary of Takeda Pharmaceuticals Company...
Corza Medical kündigt Direktvertrieb von TachoSil® auf dem US-Markt an
20 avr. 2023 14h57 HE
|
Corza Medical Inc.
WESTWOOD, Massachusetts, April 20, 2023 (GLOBE NEWSWIRE) -- Corza Medical („Corza“) gab strategische Pläne bekannt, TachoSill®, ein erstklassiges chirurgisches Fibrin-Versiegelungspflaster, dem...
Corza Medical annonce une distribution directe du TachoSil® sur le marché américain
20 avr. 2023 14h57 HE
|
Corza Medical Inc.
WESTWOOD, Massachusetts, 20 avr. 2023 (GLOBE NEWSWIRE) -- Corza Medical (« Corza ») a annoncé des plans stratégiques pour vendre directement le produit TachoSil®, un patch de colle de fibrine...
Corza Medical Announces Direct Distribution of TachoSil® to the US Market
20 avr. 2023 09h05 HE
|
Corza Medical Inc.
WESTWOOD, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- Corza Medical (“Corza”) announced strategic plans to directly sell TachoSil®, a best-in-class surgical fibrin sealant patch trusted by medical...